F-STAR THERAPEUTICS INC - COM (FSTX)

CUSIP: 30315R107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
10,852,636
Share change
+8,620,940
Total reported value
$93,200,000
Price per share
$8.59
Number of holders
39
Value change
+$74,020,075
Number of buys
27
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 30315R107?
CUSIP 30315R107 identifies FSTX - F-STAR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of F-STAR THERAPEUTICS INC - COM (FSTX) as of Q2 2021

As of 30 Jun 2021, F-STAR THERAPEUTICS INC - COM (FSTX) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,852,636 shares. The largest 10 holders included BOXER CAPITAL, LLC, Point72 Asset Management, L.P., Rock Springs Capital Management LP, PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, DAFNA Capital Management LLC, Atlas Venture Advisors, Inc., and CITADEL ADVISORS LLC. This page lists 39 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.